Media group Huntsworth (HNT) slumps 18.6% to 42.25p on a profit warning for the first half of its financial year. The short statement is optimistic on a recovery in the second half, but there's no supporting details from the owner of the Citigate, Red and Grayling public relation agencies.
Insurance services group Quindell (QPP:AIM) jumps 14.5% to 207.25p after saying that earnings and pre-tax profit will beat expectations for the first half of the year. The figures will be published on 21 August.
Mike Ashley's Sports Direct International (SPD) skips 4.3% higher to 727.75p on news it is launching in Australia and New Zealand through a partnership with online flash sales retailer MySale (MYSL:AIM). The Australian fashion sales website, in which Sports Direct has a 4.8% stake, sprints 4.9% higher to 220.25p.
Niche drug maker Shire (SHP) gains 2.6% to £49.99 after announcing it is willing to recommend a £53.20 a share offer from US outfit AbbVie to its shareholders.
Aircraft engine maker Rolls-Royce (RR.) advances 1.5% to £10.52 as it announces its new Trent 7000 engine will be exclusively used to power the new Airbus A330neo. Westhouse comments: 'Overall, given that we believe that Airbus would not have chosen to launch it at Farnborough without high confidence as to the number and quality of launch customers, and the clarity in RR's sole-source position, we see this as a small positive for RR.'
Chinese wooden cupboards-to-doors maker Jiasen International (JSI:AIM) edges up to 84.5p in debut Aim dealings. This follows a £2.3 million placing priced at 82p to help the company boost production and drive expansion.
Indian unconventional oil and gas play Oilex (OEX:AIM) gains 7.7% to 6.84p as it announces further operational progress with the key 77-H appraisal well on its flagship Cambay field. Once the well has been stabilised the company will be in a position to carry out a flow test.
Proton cancer machine maker Advanced Oncotherapy (AVO:AIM) rises 6.1% to 3p after hiring Dutch company ICT Automatisering to develop software for its cancer-fighting proprietary LIGHT accelerator machine.
